RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of BCYC
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Bicycle Therapeutics PLC stock upgraded to Sell Candidate.
(Updated on Jul 03, 2024)

Sell candidate since Jun 14, 2024 Loss -15.24% PDF

The Bicycle Therapeutics PLC stock price fell by -1.16% on the last day (Wednesday, 3rd Jul 2024) from $19.81 to $19.58. During the last trading day the stock fluctuated 2.56% from a day low at $19.50 to a day high of $20.00. The price has been going up and down for this period, and there has been a -5.64% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -206 thousand shares and in total, 64 thousand shares were bought and sold for approximately $1.26 million.

The stock has broken the wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($20.28) are considered to be a "second chance" to get out. According to the fan-theory $16.58 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BCYC Signals & Forecast

There are few to no technical positive signals at the moment. The Bicycle Therapeutics PLC stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $20.06 and $21.90. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, June 12, 2024, and so far it has fallen -19.98%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Bicycle Therapeutics PLC stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.500 between high and low, or 2.56%. For the last week the stock has had daily average volatility of 3.09%.

Bicycle Therapeutics PLC is oversold on RSI14 (10). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BCYC) For The Upcoming Trading Day Of Friday 5th

For the upcoming trading day on Friday, 5th we expect Bicycle Therapeutics PLC to open at $19.69, and during the day (based on 14 day Average True Range), to move between $18.61 and $20.55, which gives a possible trading interval of +/-$0.97 (+/-4.97%) up or down from last closing price. If Bicycle Therapeutics PLC takes out the full calculated possible swing range there will be an estimated 9.94% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $23.03, some $3.45 (17.62%) from the current price of $19.58, our system finds the risk reward not very attractive.

Is Bicycle Therapeutics PLC stock A Buy?

Bicycle Therapeutics PLC holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.593 Sell Candidate Upgraded

Predicted Opening Price for Bicycle Therapeutics PLC of Friday, July 5, 2024

Fair opening price July 5, 2024 Current price
$19.69 ( 0.579%) $19.58

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BCYC

Fibonacci Support & Resistance Levels

Level Price
R3 20.19 3.13%
R2 20.00 2.16%
R1 19.88 1.55%
Price 19.58
S1 19.50 -0.397%
S2 19.38 -1.00%
S3 19.19 -1.97%

Accumulated Volume Support & Resistance Levels

Level Price
R3 23.48 19.92%
R2 23.45 19.77%
R1 23.03 17.62%
Price 19.58
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Bicycle Therapeutics PLC Stock and on which exchange is it traded?
The symbol for Bicycle Therapeutics PLC is BCYC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Bicycle Therapeutics PLC Stock?
Bicycle Therapeutics PLC holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy Bicycle Therapeutics PLC Stock?
Bicycle Therapeutics PLC Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Bicycle Therapeutics PLC Stock.

What's the current price of Bicycle Therapeutics PLC Stock?
As of the end of day on the Jul 03, 2024, the price of an Bicycle Therapeutics PLC (BCYC) share was $19.58.

What is the 52-week high and low for Bicycle Therapeutics PLC Stock?
The 52-week high for Bicycle Therapeutics PLC Stock is $27.50 and the 52-week low is $12.54.

What is the market capitalization of Bicycle Therapeutics PLC Stock?
As of the Jul 03, 2024, the market capitalization of Bicycle Therapeutics PLC is 834.746M.

When is the next earnings date for Bicycle Therapeutics PLC?
The upcoming earnings date for Bicycle Therapeutics PLC is Aug 01, 2024.
Click to get the best stock tips daily for free!

About Bicycle Therapeutics PLC

Bicycle Therapeutics PLC Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The company's oncology product candidates also comprise BT5528, a BTC that is in a Phase I/II clinical trial ... BCYC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT